Human skin has three layers: the epidermis, the dermis, and the subcutis (underlying fat)
Studies with semaglutide show that discontinuation leads to appetite returning to baseline levels and weight regain of approximately two-thirds of the lost weight within one year
Research surrounding Epithalon focuses on its potential influence on telomerase activity, circadian rhythms, and healthy aging pathways
It is also a valuable treatment option for those seeking to enhance their cognitive performance for professional or personal reasons
Physiologically, this is often the result of sarcopenia (muscle wasting) combined with rapid fat loss in the facial pads
Of note, in the STEP 1 extension trial, participants regained roughly two-thirds of their lost weight within a year of stopping semaglutide, and improvements in blood pressure, cholesterol, and glucose largely reversed